The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, double-blind study of galunisertib+gemcitabine (GG) vs gemcitabine+placebo (GP) in patients (pts) with unresectable pancreatic cancer (PC).
 
Davide Melisi
No Relationships to Disclose
 
Rocio Garcia-Carbonero
Honoraria - Amgen (I); Boehringer Ingelheim (I); Lilly (I); Merck (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Lilly (I); Pfizer (I); Roche (I)
Research Funding - IPSEN
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim (I); Ipsen; Lilly (I); Merck; Novartis; Pfizer; Pfizer (I); Roche; Roche (I); Sanofi
 
Teresa Macarulla
No Relationships to Disclose
 
Denis Pezet
No Relationships to Disclose
 
Gael Deplanque
Research Funding - Bavarian Nordic; Exelixis; Genentech; Janssen-Cilag; Lilly; Merck Serono; Roche; Sanofi; Sotio
 
Martin Fuchs
Consulting or Advisory Role - Lilly
 
Jorg Trojan
Consulting or Advisory Role - Lilly
Speakers' Bureau - Amgen; Bayer; Merck Serono
Travel, Accommodations, Expenses - Bayer
 
Helmut Oettle
Consulting or Advisory Role - Celgene; Lilly
Speakers' Bureau - Celgene; Lilly
Research Funding - Celgene; Lilly; Roche
Travel, Accommodations, Expenses - Celgene; Medac
 
Mark Kozloff
Honoraria - Genentech; Lilly; Roche
Consulting or Advisory Role - Genentech; Lilly; Roche
Speakers' Bureau - Genentech; Lilly; Roche
 
Ann Cleverly
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Ivelina Gueorguieva
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Durisala Desaiah
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Michael M. F. Lahn
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Al Blunt
Employment - Covance
Stock and Other Ownership Interests - Covance
 
Karim A. Benhadji
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck; Merck Serono; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical